Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Response to neoadjuvant chemo for breast cancer varies by sex

Summary by Ground News
Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy are numerically lower. The analysis included 385 men and 68,065 women with BC treated with NAC. Women had twice the odds of pCR than men with BC (adjusted odds ratio, 2.0)

2 Articles

HealthDayHealthDay
Center

Response to Neoadjuvant Chemo for Breast Cancer Varies by Sex

THURSDAY, Oct. 6, 2022 (HealthDay News) -- Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus

Read Full Article
Medical XpressMedical Xpress
Center

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to a study published online Sept. 7 in Cancer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Thursday, October 6, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Breast Cancer icon

Breast Cancer

Medical icon

Medical

O'Neill icon

O'Neill

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal